Qiagen NV (QGEN) - Total Liabilities
Based on the latest financial reports, Qiagen NV (QGEN) has total liabilities worth $2.45 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore QGEN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Qiagen NV - Total Liabilities Trend (1995–2025)
This chart illustrates how Qiagen NV's total liabilities have evolved over time, based on quarterly financial data. See QGEN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Qiagen NV Competitors by Total Liabilities
The table below lists competitors of Qiagen NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
99 Speed Mart Retail Holdings Berhad
KLSE:5326
|
Malaysia | RM1.98 Billion |
|
UNO Minda Limited
NSE:UNOMINDA
|
India | Rs61.57 Billion |
|
Yes Bank Limited
NSE:YESBANK
|
India | Rs4.19 Trillion |
|
Voestalpine AG
VI:VOE
|
Austria | €7.61 Billion |
|
Allegro Microsystems Inc
NASDAQ:ALGM
|
USA | $459.73 Million |
|
DUFRY AG UNSP.ADR/010
F:D2JA
|
Germany | €14.24 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$8.31 Billion |
|
Shenyang Fortune Precision Equipment Co. Ltd. A
SHG:688409
|
China | CN¥4.39 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Qiagen NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see QGEN company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qiagen NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qiagen NV (1995–2025)
The table below shows the annual total liabilities of Qiagen NV from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $2.52 Billion | +18.64% |
| 2024-12-31 | $2.12 Billion | -8.02% |
| 2023-12-31 | $2.31 Billion | -18.21% |
| 2022-12-31 | $2.82 Billion | -7.52% |
| 2021-12-31 | $3.05 Billion | -0.70% |
| 2020-12-31 | $3.07 Billion | +13.81% |
| 2019-12-31 | $2.70 Billion | -13.31% |
| 2018-12-31 | $3.11 Billion | +24.66% |
| 2017-12-31 | $2.50 Billion | +46.82% |
| 2016-12-31 | $1.70 Billion | +4.51% |
| 2015-12-31 | $1.63 Billion | -9.39% |
| 2014-12-31 | $1.80 Billion | +31.65% |
| 2013-12-31 | $1.36 Billion | -2.64% |
| 2012-12-31 | $1.40 Billion | +16.93% |
| 2011-12-31 | $1.20 Billion | -16.62% |
| 2010-12-31 | $1.44 Billion | -4.49% |
| 2009-12-31 | $1.51 Billion | +5.16% |
| 2008-12-31 | $1.43 Billion | +3.50% |
| 2007-12-31 | $1.38 Billion | +114.14% |
| 2006-12-31 | $645.85 Million | +105.13% |
| 2005-12-31 | $314.84 Million | +0.20% |
| 2004-12-31 | $314.22 Million | +44.71% |
| 2003-12-31 | $217.14 Million | +13.40% |
| 2002-12-31 | $191.48 Million | +32.98% |
| 2001-12-31 | $143.99 Million | +119.22% |
| 2000-12-31 | $65.68 Million | +18.44% |
| 1999-12-31 | $55.45 Million | +65.04% |
| 1998-12-31 | $33.60 Million | +34.94% |
| 1997-12-31 | $24.90 Million | +34.59% |
| 1996-12-31 | $18.50 Million | +32.14% |
| 1995-12-31 | $14.00 Million | -- |
About Qiagen NV
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technol… Read more